These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35912717)

  • 21. Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
    Kim JH; Kim JW; Kim CG
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):261-268. PubMed ID: 35119292
    [No Abstract]   [Full Text] [Related]  

  • 22. Preliminary analysis of predicting the first recurrence in patients with neovascular age-related macular degeneration using deep learning.
    Jang B; Lee SY; Kim C; Park UC; Kim YG; Lee EK
    BMC Ophthalmol; 2023 Dec; 23(1):499. PubMed ID: 38062449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VALIDATION OF AN AUTOMATED FLUID ALGORITHM ON REAL-WORLD DATA OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OVER FIVE YEARS.
    Gerendas BS; Sadeghipour A; Michl M; Goldbach F; Mylonas G; Gruber A; Alten T; Leingang O; Sacu S; Bogunovic H; Schmidt-Erfurth U
    Retina; 2022 Sep; 42(9):1673-1682. PubMed ID: 35994584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
    Yang J; Zhang Q; Motulsky EH; Thulliez M; Shi Y; Lyu C; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2019 Dec; 208():1-11. PubMed ID: 31229464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].
    Book M; Ziegler M; Rothaus K; Faatz H; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Ophthalmologe; 2022 Mar; 119(3):258-264. PubMed ID: 34351479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment.
    Cho HJ; Yoon W; Yoon J; Na SK; Lee J; Kim J; Kim CG; Kim JW
    Am J Ophthalmol; 2022 Feb; 234():6-14. PubMed ID: 34339661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Shah N; Maguire MG; Martin DF; Shaffer J; Ying GS; Grunwald JE; Toth CA; Jaffe GJ; Daniel E;
    Ophthalmology; 2016 Apr; 123(4):858-64. PubMed ID: 26778329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
    Guymer RH; Markey CM; McAllister IL; Gillies MC; Hunyor AP; Arnold JJ;
    Ophthalmology; 2019 May; 126(5):723-734. PubMed ID: 30502372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration.
    Kawashima Y; Hata M; Oishi A; Ooto S; Yamashiro K; Tamura H; Miyata M; Uji A; Ueda-Arakawa N; Tsujikawa A
    Am J Ophthalmol; 2017 Sep; 181():61-70. PubMed ID: 28669776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volume-rendering three-dimensional image analysis of macular neovascularization in age-related macular degeneration.
    Choi M; Han S; Kim SW; Yun C; Oh J
    Eye (Lond); 2024 Apr; 38(6):1125-1132. PubMed ID: 38040962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy.
    Michl M; Fabianska M; Seeböck P; Sadeghipour A; Haj Najeeb B; Bogunovic H; Schmidt-Erfurth UM; Gerendas BS
    Br J Ophthalmol; 2022 Jan; 106(1):113-120. PubMed ID: 33087314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration.
    Borrelli E; Oakley JD; Iaccarino G; Russakoff DB; Battista M; Grosso D; Borghesan F; Barresi C; Sacconi R; Bandello F; Querques G
    Eye (Lond); 2024 Feb; 38(3):537-544. PubMed ID: 37670143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration.
    Pauleikhoff D; Gunnemann ML; Ziegler M; Heimes-Bussmann B; Bormann E; Bachmeier I; Yu S; Garcia Armendariz B; Pauleikhoff L
    PLoS One; 2023; 18(12):e0288861. PubMed ID: 38134207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
    Saenz-de-Viteri M; Recalde S; Fernandez-Robredo P; López Gálvez MI; Arias Barquet L; Figueroa MS; García-Arumí J; García-Layana A;
    Acta Ophthalmol; 2021 Dec; 99(8):861-870. PubMed ID: 33720541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.
    Schmidt-Erfurth U; Vogl WD; Jampol LM; Bogunović H
    Ophthalmology; 2020 Sep; 127(9):1211-1219. PubMed ID: 32327254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-neovascular age-related macular degeneration with subretinal fluid.
    Hilely A; Au A; Freund KB; Loewenstein A; Souied EH; Zur D; Sacconi R; Borrelli E; Peiretti E; Iovino C; Sugiura Y; Ellabban AA; Monés J; Waheed NK; Ozdek S; Yalinbas D; Thiele S; de Moura Mendonça LS; Lee MY; Lee WK; Turcotte P; Capuano V; Filali Ansary M; Chakravarthy U; Lommatzsch A; Gunnemann F; Pauleikhoff D; Ip MS; Querques G; Holz FG; Spaide RF; Sadda S; Sarraf D
    Br J Ophthalmol; 2021 Oct; 105(10):1415-1420. PubMed ID: 32920528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.
    Ohji M; Okada AA; Sasaki K; Moon SC; Machewitz T; Takahashi K;
    Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3637-3647. PubMed ID: 34283294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMD.
    Ehlers JP; Patel N; Kaiser PK; Heier JS; Brown DM; Meng X; Reese J; Lunasco L; Le TK; Hu M; Srivastava SK
    Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):17. PubMed ID: 35713892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.